Royce & Associates’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-12,344
| Closed | -$18K | – | 1023 |
|
|
2020
Q3 | $18K | Buy |
12,344
+1,135
| +10% | +$1.66K | ﹤0.01% | 987 |
|
|
2020
Q2 | $22K | Buy |
11,209
+1,020
| +10% | +$2K | ﹤0.01% | 1113 |
|
|
2020
Q1 | $20K | Buy |
10,189
+4,769
| +88% | +$9.36K | ﹤0.01% | 1088 |
|
|
2019
Q4 | $22K | Buy |
+5,420
| New | +$22K | ﹤0.01% | 1095 |
|
|
2016
Q2 | – | Sell |
-340,589
| Closed | -$4.07M | – | 1094 |
|
|
2016
Q1 | $4.07M | Buy |
340,589
+81,000
| +31% | +$968K | 0.03% | 671 |
|
|
2015
Q4 | $3.46M | Sell |
259,589
-74,785
| -22% | -$995K | 0.02% | 724 |
|
|
2015
Q3 | $3.59M | Sell |
334,374
-42,700
| -11% | -$459K | 0.02% | 731 |
|
|
2015
Q2 | $3.04M | Sell |
377,074
-24,902
| -6% | -$200K | 0.01% | 858 |
|
|
2015
Q1 | $2.66M | Hold |
401,976
| – | – | 0.01% | 884 |
|
|
2014
Q4 | $2.56M | Buy |
401,976
+11,100
| +3% | +$70.7K | 0.01% | 933 |
|
|
2014
Q3 | $3.86M | Sell |
390,876
-21,429
| -5% | -$212K | 0.01% | 866 |
|
|
2014
Q2 | $4.65M | Sell |
412,305
-192,543
| -32% | -$2.17M | 0.01% | 872 |
|
|
2014
Q1 | $7.33M | Hold |
604,848
| – | – | 0.02% | 775 |
|
|
2013
Q4 | $7.62M | Sell |
604,848
-22,857
| -4% | -$288K | 0.02% | 763 |
|
|
2013
Q3 | $10.4M | Hold |
627,705
| – | – | 0.03% | 642 |
|
|
2013
Q2 | $9.54M | Buy |
+627,705
| New | +$9.54M | 0.03% | 646 |
|